Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | March 1, 1996 |
| Phase: | Phase II |
| Status: | Terminated |
| NCT ID: | NCT00003508 |
| Study Type: | Interventional |
| Intervention: | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Burzynski Research Institute |
| Ages: | Child|Adult|Senior |
| Enrollment: | 40 |
| Funded By: | Other |
| First Received: | November 1, 1999 |
| End Date: | |
| Last Updated: | August 31, 2009 |
| Last Verified: | June 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
